What Is IPMN, and When Is Surgery Needed?

The three subtypes of IPMN

• Main-duct type: involves the main pancreatic duct itself; generally needs closer follow-up or surgical evaluation
• Branch-duct type: develops in the small side branches off the main duct; can often be safely followed for a long time
• Mixed type: involves both the main duct and branch ducts, and is generally treated similarly to main-duct type

What are high-risk stigmata?

Current guidelines distinguish between two groups of findings in IPMN assessment: 'high-risk stigmata' and 'worrisome features.' High-risk stigmata include jaundice together with a cyst in the head of the pancreas, a solid component within the cyst wall seen on imaging, and marked dilation of the main pancreatic duct; when these are present, surgical evaluation is given priority.

Worrisome features call for a more measured approach: moderate duct dilation, a cyst above a certain size, a thickened cyst wall, or noticeable growth over a short time. These features on their own don't necessarily mean surgery — they usually lead to closer evaluation with EUS and/or fluid sampling.

The decision is never based on size alone

Simple size thresholds used to guide decisions in the past; current practice instead calls for weighing all the findings together. For example, a relatively small cyst with an accompanying feature such as wall thickening or duct dilation may need closer attention, while a larger but otherwise quiet-looking cyst can be safely followed for a long time.

This means there is no single answer to 'my cyst is this many centimeters — should I have surgery?' The imaging findings need to be considered as a whole.

Other factors that shape the decision

• The patient's age and expected life expectancy
• Coexisting heart, lung, or other systemic conditions and the associated surgical risk
• The recovery process and possible complications of major pancreatic surgery (particularly large resections such as the Whipple procedure)
• The patient's own preference and willingness to accept close follow-up
• Whether the IPMN is confined to one area of the pancreas or present in multiple locations

How is follow-up done when surgery isn't recommended?

For branch-duct IPMN without high-risk stigmata or worrisome features, regular MRI/MRCP follow-up is a safe approach for most patients. If a new finding appears during follow-up — growth, wall thickening, duct dilation — the case is reassessed, and EUS may be added if needed.

New symptoms that develop during follow-up, such as weight loss, new-onset diabetes, or abdominal pain, are also part of the assessment; these can act as additional warning signs beyond imaging alone.

Is follow-up needed after surgery?

In patients who have had part of the pancreas removed for IPMN, regular imaging follow-up is still recommended afterward, since a new IPMN focus can develop in the remaining pancreatic tissue. This doesn't mean the surgery 'failed' — it simply reflects that IPMN can affect more than one area of the pancreas.